Roivant Sciences Ltd. (ROIV)
28.54
+1.02
(+3.69%)
USD |
NASDAQ |
Apr 30, 16:00
28.54
0.00 (0.00%)
After-Hours: 20:00
Roivant Sciences Price to Book Value : 4.784 for April 30, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Arbutus Biopharma Corp. | 10.73 |
| Moderna, Inc. | 2.104 |
| GSK Plc | 4.740 |
| Centessa Pharmaceuticals Plc | 11.58 |
| Silence Therapeutics Plc | 5.368 |
Price to Book Value Related Metrics
| PS Ratio | 1482.17 |
| PEG Ratio | -0.0345 |
| Price | 28.54 |
| Earnings Yield | -4.09% |
| Market Cap | 20.42B |
| PEGY Ratio | -0.0345 |